GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kunming Longjin Pharmaceutical Co Ltd (SZSE:002750) » Definitions » Cyclically Adjusted Book per Share

Kunming Longjin Pharmaceutical Co (SZSE:002750) Cyclically Adjusted Book per Share : ¥1.60 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kunming Longjin Pharmaceutical Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Kunming Longjin Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2024 was ¥1.267. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥1.60 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Kunming Longjin Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 1.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-05-24), Kunming Longjin Pharmaceutical Co's current stock price is ¥3.04. Kunming Longjin Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ¥1.60. Kunming Longjin Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.90.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Kunming Longjin Pharmaceutical Co was 7.38. The lowest was 2.07. And the median was 6.06.


Kunming Longjin Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Kunming Longjin Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kunming Longjin Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Kunming Longjin Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 1.61

Kunming Longjin Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.58 1.59 1.61 1.61 1.60

Competitive Comparison of Kunming Longjin Pharmaceutical Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Kunming Longjin Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kunming Longjin Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kunming Longjin Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kunming Longjin Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Kunming Longjin Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Kunming Longjin Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.267/115.2271*115.2271
=1.267

Current CPI (Mar. 2024) = 115.2271.

Kunming Longjin Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.828 98.200 0.972
201409 0.884 98.900 1.030
201412 0.952 99.000 1.108
201503 1.504 99.900 1.735
201506 1.415 99.500 1.639
201509 1.452 100.500 1.665
201512 1.497 100.600 1.715
201603 1.537 102.200 1.733
201606 1.531 101.400 1.740
201609 1.630 102.400 1.834
201612 1.674 102.600 1.880
201703 1.709 103.200 1.908
201706 1.582 103.100 1.768
201709 1.601 104.100 1.772
201712 1.612 104.500 1.777
201803 1.630 105.300 1.784
201806 1.609 104.900 1.767
201809 1.618 106.600 1.749
201812 1.616 106.500 1.748
201903 1.630 107.700 1.744
201906 1.620 107.700 1.733
201909 1.620 109.800 1.700
201912 1.559 111.200 1.615
202003 1.548 112.300 1.588
202006 1.555 110.400 1.623
202009 1.564 111.700 1.613
202012 1.588 111.500 1.641
202103 1.595 112.662 1.631
202106 1.600 111.769 1.650
202109 1.605 112.215 1.648
202112 1.596 113.108 1.626
202203 1.598 114.335 1.610
202206 1.590 114.558 1.599
202209 1.588 115.339 1.586
202212 1.456 115.116 1.457
202303 1.435 115.116 1.436
202306 1.416 114.558 1.424
202309 1.389 115.339 1.388
202312 1.278 114.781 1.283
202403 1.267 115.227 1.267

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Kunming Longjin Pharmaceutical Co  (SZSE:002750) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Kunming Longjin Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.04/1.6
=1.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Kunming Longjin Pharmaceutical Co was 7.38. The lowest was 2.07. And the median was 6.06.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Kunming Longjin Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Kunming Longjin Pharmaceutical Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Kunming Longjin Pharmaceutical Co (SZSE:002750) Business Description

Traded in Other Exchanges
N/A
Address
789 Lanmao Road, High-tech Zone, Majinpu, Kunming, CHN, 650503
Kunming Longjin Pharmaceutical Co Ltd is a pharmaceutical company. It develops, produces and sells natural botanical and chemical freeze-dried powder injections. It also has freeze-dried powder injection line. Its products include Chinese medicine, biochemical medicine, chemical medicine, cardio-cerebral vascular medicine, digestive system medicine, immune system medicine, vitamins, minerals, enteral and parenteral nutrition.
Executives
Fan Xian E Director
Zhang Cheng Rong Independent director

Kunming Longjin Pharmaceutical Co (SZSE:002750) Headlines

No Headlines